Imagine what's possible - HSV 2, page-115

A few days ago I loaded a lot of info about HSV-2 characteristics in with the question about SP behavior after release of un-blinded results .... I probably just confused the main issue.

Silverfox put it much more simply "If results are excellent, as I anticipate, this long and dismal period in purgatory for AHZ will be over in a twinkle" ... although it brings me back to my original question.

Given that we don't have enough money to undertake a Phase 3 trial .... probable cost several tens of millions ... what will be the share price response after release of un-blinded results, assuming they are excellent results ... time scale and dollar scale.... Silverfox's "twinkle"

If the good Professor starts the sales /licencing process among the CSL-type companies of this world after release of results, isn't it going to be the case that the SP will only move when their money hits our account ... say 6 months? ... nothing much happens until then? ... or at least until the time in the future (6 months?) when details of a deal are announced.

Wot thinks u?